Advertisement
Singapore markets open in 2 minutes
  • Straits Times Index

    3,296.89
    +4.20 (+0.13%)
     
  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     
  • Dow

    38,225.66
    +322.37 (+0.85%)
     
  • Nasdaq

    15,840.96
    +235.48 (+1.51%)
     
  • Bitcoin USD

    59,038.11
    +1,404.69 (+2.44%)
     
  • CMC Crypto 200

    1,269.59
    -1.15 (-0.09%)
     
  • FTSE 100

    8,172.15
    +50.91 (+0.63%)
     
  • Gold

    2,311.40
    +1.80 (+0.08%)
     
  • Crude Oil

    79.26
    +0.31 (+0.39%)
     
  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     
  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     
  • Hang Seng

    18,207.13
    +444.10 (+2.50%)
     
  • FTSE Bursa Malaysia

    1,580.30
    +4.33 (+0.27%)
     
  • Jakarta Composite Index

    7,117.42
    -7,234.20 (-50.41%)
     
  • PSE Index

    6,646.55
    -53.94 (-0.81%)
     

Chemours (CC) Just Reclaimed the 50-Day Moving Average

From a technical perspective, Chemours (CC) is looking like an interesting pick, as it just reached a key level of support. CC recently overtook the 50-day moving average, and this suggests a short-term bullish trend.

One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of an up or down trend.

CC could be on the verge of another rally after moving 42.4% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.

Once investors consider CC's positive earnings estimate revisions, the bullish case only solidifies. No estimate has gone lower in the past two months for the current fiscal year, compared to 1 higher, and the consensus estimate has increased as well.

ADVERTISEMENT

With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on CC for more gains in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Chemours Company (CC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research